Ear Acupuncture for Acute Sore Throat in Patients Unable to Take Non-steroidal Anti-inflammatory Agents (NSAIDs)
| Tracking Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| First Received Date ICMJE | February 18, 2011 | ||||||||
| Last Updated Date | April 19, 2012 | ||||||||
| Start Date ICMJE | October 2011 | ||||||||
| Estimated Primary Completion Date | December 2012 (final data collection date for primary outcome measure) | ||||||||
| Current Primary Outcome Measures ICMJE |
Reduction in pain [ Time Frame: 5 months ] [ Designated as safety issue: No ] Does ear acupuncture alone significantly reduce pain in acute sore throat? |
||||||||
| Original Primary Outcome Measures ICMJE | Same as current | ||||||||
| Change History | Complete list of historical versions of study NCT01301482 on ClinicalTrials.gov Archive Site | ||||||||
| Current Secondary Outcome Measures ICMJE | Not Provided | ||||||||
| Original Secondary Outcome Measures ICMJE | Not Provided | ||||||||
| Current Other Outcome Measures ICMJE | Not Provided | ||||||||
| Original Other Outcome Measures ICMJE | Not Provided | ||||||||
| Descriptive Information | |||||||||
| Brief Title ICMJE | Ear Acupuncture for Acute Sore Throat in Patients Unable to Take Non-steroidal Anti-inflammatory Agents (NSAIDs) | ||||||||
| Official Title ICMJE | Ear Acupuncture for Acute Sore Throat in Patients Unable to Take Non-steroidal Anti-inflammatory Agents (NSAIDs) | ||||||||
| Brief Summary | The purpose of this study is to assess the effect of ear acupuncture alone in subjects with a contraindication to anti-inflammatory medications in the reduction of pain and hours lost from work in acute sore throat. |
||||||||
| Detailed Description | Subjects (MOFH personnel & DoD beneficiaries)that are 18 years or older with a chief complaint of acute sore throat who have one of the inclusion criteria will be booked for appointments in the Acute Sore Throat Clinic. At the time of check-in the subject will be screened by the technician and will be asked the screening questions for exclusion criteria (See attached instrument). If the subject is eligible for inclusion into the study, the Informed Consent process will be performed and documented by someone on the study staff. The PI will have the AI or Study staffs recruit their patients to prevent any misconception of coercion. The inclusion/exclusion criteria will be verified in Armed Forces Health Longitudinal Technology Application (AHLTA). The investigator will evaluate the subject and further determine any further exclusion criteria based on exam. The subject will have adequate time to ask questions concerning the study and will sign the Informed Consent Document and HIPAA Authorization Form prior to any study-related procedures being performed. The subject will get a throat culture and will receive ear acupuncture. If throat culture is positive, patients will be notified and referred to their Primary Care Manager to be prescribed standard of care antibiotics. The ear will be cleansed with an alcohol swab prior to ear acupuncture. Subjects will be asked 15 minutes after their treatment to assess their pain on a scale of 0-10 (with 10 being the worst pain). After the subject has left the clinic, phone calls will be made at 6 hours, 24 hours and 48 hours to assess their pain level and ask about their missed hours from work(see attached telephone data collection tool). Subjects who report back after 48 hours with unimproved sore throat will be instructed to make a same day follow up with the clinic. Ear acupuncture utilizes up to 10 needles (see figure 6). If at any point the subject decides not to continue with the placing of the needles, the acupuncture will cease and the number of points will be documented. The ear Acupuncture points on the right ear include Cingulate gyrus, thalamus, omega 2, shen-men, point zero. The ear Acupuncture points on the left ear include Cingulate gyrus, thalamus, omega 2, shen-men, point zero (see figures 1-5). Subject's participation in this study is completed after 48 hours. Patients will be instructed to have no heavy meals, excessive hot or cold foods, heavy exercise or intercourse and no alcohol for 24 hours. Ear needles will fall out on their own within the next 6 days. We anticipate that the ear acupuncture will improve the reduction in pain by 2 points on a 10 point scale (with 10 being the worst pain). (0-10 point scale) The risks associated with the use of ear acupuncture needles include: pain, bleeding, infection (very rare) and flare of signs and symptoms. In the event the acupuncture needles do not fall out within 6 days, patients will be instructed to come in and have them removed by one of the Investigators. In this study we are using Sedatelec ASP Original Gold needles. These acupuncture needles are sterile, gold plated semi permanent ear acupuncture needles for single use. (see figure 6) All investigators are certified in Battlefield Acupuncture and have certification in the MOFH Credentials file. If at any time during the study, the subject decides to withdraw from the study, they can come in and have the ear acupuncture needles removed by one of the Investigators. If a subject becomes pregnant during the study, they will be withdrawn from the study and the acupuncture needles will be removed. If patients are withdrawn from the study, they will have the option to either have the acupuncture needles removed by one of the investigators or allow them to fall out on their own. Patients must agree to take precautions to prevent pregnancy during the course of this study. The only completely reliable methods of birth control are total abstinence or surgical removal of the uterus. Other methods, such as the use of condoms, a diaphragm or cervical cap, birth control pills, IUD, or sperm killing products are not totally effective in preventing pregnancy. Also, women who are breastfeeding may not participate in this study. The Food and Drug Administration (FDA) regulates acupuncture needles as a class II medical device because they are intended for use in the cure, mitigation, treatment, or prevention of disease in man or are intended to affect the structure or function of the body of man. The FDA regulates the acupuncture needles (see 21 CFR 880.5580), but not the practice of acupuncture itself. The needles being used are Sedatelec ASP Original Gold needles, which are approved by the FDA for use in acupuncture and will be used in accordance with their FDA approved labeling. |
||||||||
| Study Type ICMJE | Interventional | ||||||||
| Study Phase | Not Provided | ||||||||
| Study Design ICMJE | Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
||||||||
| Condition ICMJE | Acute Sore Throat | ||||||||
| Intervention ICMJE | Device: Ear Acupuncture
Ear acupuncture utilizes up to 10 needles (see figure 6). If at any point the subject decides not to continue with the placing of the needles, the acupuncture will cease and the number of points will be documented. The ear Acupuncture points on the right ear include Cingulate gyrus, thalamus, omega 2, shen-men, point zero. The ear Acupuncture points on the left ear include Cingulate gyrus, thalamus, omega 2, shen-men, point zero (see figures 1-5). |
||||||||
| Study Arm (s) | Not Provided | ||||||||
| Publications * | Not Provided | ||||||||
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|||||||||
| Recruitment Information | |||||||||
| Recruitment Status ICMJE | Recruiting | ||||||||
| Estimated Enrollment ICMJE | 33 | ||||||||
| Estimated Completion Date | December 2012 | ||||||||
| Estimated Primary Completion Date | December 2012 (final data collection date for primary outcome measure) | ||||||||
| Eligibility Criteria ICMJE | Inclusion:
Exclusion:
|
||||||||
| Gender | Both | ||||||||
| Ages | 18 Years and older | ||||||||
| Accepts Healthy Volunteers | No | ||||||||
| Contacts ICMJE |
|
||||||||
| Location Countries ICMJE | United States | ||||||||
| Administrative Information | |||||||||
| NCT Number ICMJE | NCT01301482 | ||||||||
| Other Study ID Numbers ICMJE | FWH20110009H | ||||||||
| Has Data Monitoring Committee | No | ||||||||
| Responsible Party | Mike O'Callaghan Federal Hospital | ||||||||
| Study Sponsor ICMJE | Mike O'Callaghan Federal Hospital | ||||||||
| Collaborators ICMJE | Not Provided | ||||||||
| Investigators ICMJE |
|
||||||||
| Information Provided By | Mike O'Callaghan Federal Hospital | ||||||||
| Verification Date | April 2012 | ||||||||
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|||||||||